Q-State Biosciences is a drug discovery company with a unique technology platform for probing electrically excitable cells. The company combines world-leading expertise in stem cell biology, optogenetics, instrumentation, and data analysis.
Q-State’s cellular models recreate aspects of disease-relevant human biology in a robust screening-ready format. Q-State’s all-optical electrophysiology platform probes electrical activity in primary and human iPSC-derived neurons and cardiomyocytes, and in heterologously expressed ion channels. These functional assays connect patient genetics directly to in vivo pharmacology.